SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001038133-21-000002
Filing Date
2021-01-12
Accepted
2021-01-12 16:57:11
Documents
16
Period of Report
2021-01-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hska-20210112.htm   iXBRL 8-K 44116
2 EX-99.1 ex991hasenmaierappointment.htm EX-99.1 8858
8 LOGO heskalogoa051.jpg GRAPHIC 45126
  Complete submission text file 0001038133-21-000002.txt   268658

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20210112.xsd EX-101.SCH 2415
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hska-20210112_cal.xml EX-101.CAL 708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hska-20210112_def.xml EX-101.DEF 1645
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20210112_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20210112_pre.xml EX-101.PRE 12644
9 EXTRACTED XBRL INSTANCE DOCUMENT hska-20210112_htm.xml XML 19054
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22427 | Film No.: 21524075
SIC: 2835 In Vitro & In Vivo Diagnostic Substances